Quipt Home Medical Corp. 8-K

What Happened Quipt Home Medical Corp. announced a definitive arrangement agreement (entered Dec 14, 2025) under which 1567208 B.C. Ltd. (the Purchaser), together with REM Aggregator, LLC (the Parent), will acquire all outstanding Quipt common shares for $3.65 per share in cash via a plan of arrangement under the British Columbia Business Corporations Act. The Hart-Scott-Rodino (HSR) waiting period for the transaction expired at 11:59 p.m. on January 22, 2026, which satisfies one regulatory condition to closing; the transaction remains subject to other customary closing conditions, including Quipt shareholder approval.

Key Details

• Purchase price: $3.65 per Quipt common share, payable in cash.
• Agreement date: Definitive Arrangement Agreement signed December 14, 2025.
• HSR clearance: Applicable HSR waiting period expired Jan 22, 2026 (11:59 p.m.).
• Remaining conditions: Closing still requires other customary approvals (including shareholder and court approvals) and satisfaction of other closing conditions; proxy/management information circular will be filed and mailed to securityholders.

Why It Matters This filing confirms a near-term, cash acquisition valued at $3.65 per share and reports a milestone HSR expiration—reducing one regulatory hurdle toward closing. However, the deal is not final: shareholder and other approvals are still required, and the company cautions that timelines and completion are subject to customary risks and conditions. Quipt shareholders should review the forthcoming definitive management information circular and proxy statement (to be filed on EDGAR and SEDAR+) before making any voting or investment decisions.